Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix
Frumovitz, M., Munsell, M.F., Burzawa, J.K., Byers, L.A., Ramalingam, P., Brown, J., Coleman, R.L.Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.10.040
Date:
November, 2016
File:
PDF, 349 KB
english, 2016